Electric Muscle Stimulation for Patients With Chronic Respiratory Failure
NCT ID: NCT01930643
Last Updated: 2019-07-08
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
13 participants
INTERVENTIONAL
2013-08-21
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Hypothesis: Electric muscle stimulation(EMS) will improve their muscle strength and shorten their ventilator days.
Design: Randomized controlled trial. Adult patients with mechanical ventilation more than 14 days are eligible. EMS would be applied in experimental group 32 minutes/day on their bilateral thigh.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Different Electric Muscle Stimulation in Patients With Severe Sepsis and Respiratory Failure
NCT01895647
Transcutaneous Electrical Diaphragmatic Stimulation in PMV Patients
NCT04281810
Effect of Electrical Muscle Stimulation in Critically Ill Patients
NCT01637467
Effects of Neuromuscular Electrical Stimulation on Exercise Capacity in Respiratory Critically Ill Patients
NCT03083652
Use of Neuromuscular Electrostimulation (NMES) for Treatment or Prevention of ICU-Associated Weakness
NCT00709124
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
EMS would be applied in experimental group 32 minutes/day on their bilateral thigh(quadriceps muscle).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Electric muscle stimulation(EMS)
EMS:use programmed middle frequency electric stimulation device(HELEX 573)for both quadriceps stimulation, 32 minutes per day, 5 time per week.
EMS
HELEX 573 : strength aggravation mode with middle frequency carrier(1500Hz), minimal voltage for visible muscle contraction(maximum output is 75mA) , 32 minutes per day.
Control
Patients with routine passive rehabilitation program.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EMS
HELEX 573 : strength aggravation mode with middle frequency carrier(1500Hz), minimal voltage for visible muscle contraction(maximum output is 75mA) , 32 minutes per day.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No ability for active endurance exercise because of poor consciousness or limb weakness.
Exclusion Criteria
* Limb wound/infection interfered with electric pad application
* Recent acute myocardial infarction or life-threatening arrhythmia
* Uncontrolled epilepsy
* Dying patients without attempt of ventilator weaning
* Absence of respiratory drive
20 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mackay Memorial Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kuang-Hua Cheng, MD
Visiting staff
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kuang H Cheng, MD
Role: PRINCIPAL_INVESTIGATOR
Mackay Memorial Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mackay Memorial Hospital
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
13MMHIS070
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.